Search

everythinglearnresearchcommunity

for

Search:↓

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

CD34+ hair follicle stem cells can become melanin-producing cells for treating skin conditions.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Using a specific binding agent and low doses of FK506 can stimulate stem cells, speeding up skin healing by 25% and improving skin quality in rats and mice.

Removing vitamin D and calcium receptors in mice skin cells slows down skin wound healing.

Lnc056 helps hair follicle stem cells grow by increasing TRIP6 expression.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

Upadacitinib improved multiple immune-related conditions in one patient.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

Deleting TNFα gene reduces skin cancer risk in certain mice.

Understanding cellular interactions in VCA may lead to better treatments and reduce rejection.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Certain gene variations may increase the risk and severity of alopecia areata.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Cathelicidins could treat skin issues but face challenges like safety and resistance.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Blocking LFA-1 prevents hair loss in mice.

Anti-CD19 therapy may help treat SLE and NMOSD.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

A new mouse mutation causes skin and hair defects due to a gene change.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

Telocytes in silky fowl embryos develop distinct features and connections by the 20th day of incubation.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.